ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

rotigotine

Also written as “Rotigotine”, “SPM 962” and “Rotigotine transdermal patch”.

Its studies are mostly in Parkinson Disease · Restless Legs Syndrome · Fibromyalgia, led by 5 companies.

Drug pageRotigotine: every studyMany companies study it; this page follows only the 63 they lead. All 77 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Dec 21, 200763 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
UCB500 open or runningphase 4since Dec 21, 2007Aug 24, 2005none ahead
Otsukaits history only100 open or runningphase 3since Sep 27, 2007Sep 27, 2007none ahead
Eva Pharmaits history only11 open or runningno phasesince May 30, 2025May 30, 2025none ahead
Inflamax Researchits history only10 open or runningphase 1since Feb 25, 2016Feb 25, 2016none ahead
Luye Pharma Groupits history only10 open or runningphase 1since Mar 31, 2016Mar 31, 2016none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of UCB only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 35 studies since Aug 24, 2005.

  1. Mar 26, 2012Phase 1 study in Healthy VolunteersNCT01565018 · 55 enrolled · Germany
  2. Mar 30, 2012Phase 3 study in Restless Legs SyndromeNCT01569464 · 150 enrolled · United States
  3. Jul 18, 20122 phase 3 studies in Parkinson DiseaseNCT01646268, NCT01646255
  4. Aug 27, 2012Phase 1 study in HealthyNCT01675024 · 24 enrolled · China
  5. Oct 18, 2012Phase 4 study in Advanced Idiopathic Parkinson's DiseaseNCT01711866 · 87 enrolled · United States, Korea, Republic of, Malaysia and more
  6. Nov 6, 2012Phase 3 study in Advanced Parkinson's DiseaseNCT01723904 · 90 enrolled · Australia, Korea, Republic of, Malaysia and more
  7. Dec 5, 2012Phase 4 study in Parkinson DiseaseNCT01744496 · 68 enrolled · United States, Germany, Poland and more
  8. Jan 3, 2013Phase 1 study in HealthyNCT01761526 · 50 enrolled · Germany
  9. Jan 30, 2013Phase 4 study in Parkinson DiseaseNCT01782222 · 122 enrolled · United States, Austria, Hungary and more
  10. May 10, 2013Phase 1 study in HealthyNCT01854216 · 26 enrolled · Germany
  11. Oct 14, 2013Phase 1 study in Parkinson DiseaseNCT01964573 · 48 enrolled · Korea, Republic of
  12. Aug 29, 2014Phase 1 study in Parkinson DiseaseNCT02230904 · 57 enrolled · Germany
  13. Oct 31, 2018Phase 3 study in Restless Legs SyndromeNCT03728933 · 23 enrolled · United States
  14. Jun 17, 2019Phase 3 study in Restless Legs SyndromeNCT03992196 · 10 enrolled · United States

TargetBeta

“D2-like dopamine receptor agonist”ChEMBL 37, by rule

Other programs on the same three targets

ProgramCompanyFurthest phaseStudies
OlanzapineruleEli Lillyphase 476
PramipexoleruleBoehringer Ingelheimphase 444

Studies

All 50 UCB leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT03992196Restless Legs Syndrome · United States3TerminatedSep 1, 202210
NCT03728933Restless Legs Syndrome · United States3TerminatedJul 25, 202223
NCT02230904Parkinson Disease · Germany1CompletedNov 201457
NCT01964573Parkinson Disease · Korea, Republic of1CompletedFeb 200748
NCT01854216Healthy · Germany1CompletedMar 200326
NCT01782222Parkinson Disease · United States, Austria, Hungary and more4CompletedJan 2014122
NCT01761526Healthy · Germany1CompletedOct 200250
NCT01744496Parkinson Disease · United States, Germany, Poland and more4CompletedDec 201368
NCT01723904Advanced Parkinson's Disease · Australia, Korea, Republic of, Malaysia and more3CompletedMar 201390
NCT01711866Advanced Idiopathic Parkinson's Disease · United States, Korea, Republic of, Malaysia and more4CompletedMar 201387
NCT01675024Healthy · China1CompletedSep 201224
NCT01646268Parkinson Disease · China3CompletedMay 2014249
NCT01646255Parkinson Disease · China3CompletedOct 2014346
NCT01569464Restless Legs Syndrome · United States3CompletedApr 2013150
NCT01565018Healthy Volunteers · Germany1CompletedJul 201255
NCT01537042Restless Legs Syndrome · United States, Austria, Finland and more3CompletedOct 201330
NCT01536015Advanced Parkinson's Disease · United States3TerminatedOct 201325
NCT01523301Parkinson Disease · Korea, Republic of4CompletedOct 2014380
NCT01498120Restless Legs Syndrome · United States2CompletedDec 201514
NCT01495793Restless Legs Syndrome · United States2CompletedMay 201442
NCT01455012Restless Legs Syndrome · Germany4CompletedMay 201281
NCT01338896Parkinson Disease · Austria, Germany, United Kingdom1CompletedMay 201156
NCT01300819Parkinson Disease · Austria, Belgium, Bulgaria and more4CompletedOct 2012349
NCT01059903Healthy Volunteers · Germany1CompletedFeb 201050
NCT00957944Healthy Volunteers · Germany1CompletedAug 200940
NCT00881894Healthy · Germany1CompletedNov 200852
NCT00599196Early Stage Parkinson's Disease · Australia, Austria, Belgium and more3CompletedDec 2008381
NCT00594386Parkinson Disease · United States, Canada3CompletedDec 2008258
NCT00594165Parkinson Disease · United States, Canada3CompletedNov 2008217
NCT00594464Parkinson Disease · Germany4CompletedMay 200814
NCT00593606Parkinson Disease3CompletedDec 2007124
NCT00522379Parkinson Disease · United States, Chile, India and more3CompletedJul 2011514
NCT00519532Parkinson Disease · United States, Australia, Finland and more3TerminatedMay 200984
NCT00505687Parkinson Disease · United States, Austria, Germany and more3CompletedDec 2008186
NCT00501969Advanced Stage Parkinson's Disease · Australia, Austria, Croatia and more3CompletedDec 2008395
NCT00498186Restless Legs Syndrome · Austria, Germany, Spain2CompletedApr 2009295
NCT00498108Restless Legs Syndrome · Germany3CompletedSep 2007341
NCT00474058Parkinson Disease · United States, Australia, Austria and more3CompletedMar 2009287
NCT00464737Fibromyalgia · United States2CompletedNov 2008230
NCT00389831Restless Legs Syndrome · Germany2CompletedNov 200644
NCT00296192Parkinson Disease2CompletedJun 200682
NCT00292227Parkinson Disease · South Africa1CompletedSep 2006130
NCT00275236Restless Legs Syndrome · Germany3CompletedJul 200660
NCT00263068Restless Legs Syndrome · United States3CompletedDec 2007279
NCT00244387Parkinson Disease · Germany3CompletedJul 2005506
NCT00243971Parkinson Disease · Germany3CompletedOct 2005
NCT00243945Parkinson Disease · Germany3CompletedJul 200558
NCT00242008Parkinson Disease · United States3CompletedJul 2005
NCT00136045Restless Legs Syndrome · Germany3CompletedAug 2006549
NCT00135993Restless Legs Syndrome · United States3CompletedNov 2006811

How it is read

Names in the registry

  • “Rotigotine”, 39 entries
  • “SPM 962”, 13 entries
  • “Rotigotine transdermal patch”, 4 entries
  • “Rotigexole 8 mg”, 1 entry
  • “Rotigotine 1 mg/24 h”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.